Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4907726 | 0.88 | CA1 (0.46) | CA1CA2CA12CA7CA13 | |
| SCHEMBL187613 | 0.81 | CA1 (0.55) | CA1CA2CA12CA7CA13 | |
| Hydrochloric Acid SCHEMBL4349881 | 0.78 | CA1 (0.52) | CA1CA2CA12CA7CA13 | |
| SCHEMBL22023634 | 0.71 | CA1 (0.41) | CA1CA2CA12CA7CA13 | |
| SCHEMBL8059165 | 0.69 | CA1 (0.50) | CA1CA2CA12CA7CA13 | |
| SCHEMBL18593304 | 0.69 | CA1 (0.39) | CA1CA2CA12CA7CA13 | |
| SCHEMBL245064 | 0.69 | — | — | |
| SCHEMBL18593300 | 0.67 | CA1 (0.43) | CA1CA2CA12CA7CA13 | |
| SCHEMBL5507480 | 0.67 | CA1 (0.31) | CA1CA2 | |
| SCHEMBL10616331 | 0.65 | CA12 (0.46) | CA1CA2CA12CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8642497-B2 | Processes for the preparation of tetrakis(Faryl)borate salts | ALBEMARLE CORPORATION (US) | 2014-02-04 | — | — | US | claimed |
| US-20080306302-A1 | Processes for the Preparation of Tetrakis(F Aryl)Borate Salts | W. R. GRACE & CO-CONN. | 2008-12-11 | — | — | US | claimed |
| US-8642497-B2 | Processes for the preparation of tetrakis(Faryl)borate salts | ALBEMARLE CORPORATION (US) | 2014-02-04 | — | — | US | disclosed |
| US-20080306302-A1 | Processes for the Preparation of Tetrakis(F Aryl)Borate Salts | W. R. GRACE & CO-CONN. | 2008-12-11 | — | — | US | disclosed |
| EP-1960407-A1 | PROCESSES FOR THE PREPARATION OF TETRAKIS (FARYL) BORATE SALTS | ALBEMARLE CORPORATION (US) | 2008-08-27 | — | — | EP | disclosed |
| WO-2007070770-A1 | PROCESSES FOR THE PREPARATION OF TETRAKIS (FARYL) BORATE SALTS | ALBEMARLE CORPORATION (US) | 2007-06-21 | — | — | WO | disclosed |
| US-6635597-B1 | L+ B-(C6F5)3(C10F7), where L is a cation and B- is a boron anion; addition polymerization catalyst | NORTHWESTERN UNIVERSITY | 2003-10-21 | — | — | US | disclosed |
| EP-1000068-A1 | PERFLUORONAPHTHYL SUBSTITUTED BORON CONTAINING CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 2000-05-17 | — | — | EP | disclosed |
| WO-1999006412-A1 | PERFLUORONAPHTHYL SUBSTITUTED BORON CONTAINING CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 1999-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306302-A1 | Processes for the Preparation of Tetrakis(F Aryl)Borate Salts | NBAS, TBCB, TBC1D15 | CA1 1427/4885CA2 814/4885CA12 1248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.